covid-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Control group: routine treatment based on physician's order. Intervention 2: Intervention group: routine treatment based on physician's order and simospan syrup (every 8 hours 6 cc fo
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age limitation (30-60 years old) Hospitalized patients with CT-scan findings in favor of Covid-19 disease Hospitalized patients with the amount of blood oxygen saturation below 93% Hospitalized patients with Chest X-ray findings in favor of pneumonia Hospitalized patients without underlying disease
Exclusion criteria
Exclusion criteria: Pregnancy and lactation End-stage Covid-19 patients Patients diagnosed with underlying disease and organ damage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The spent time to illness improvement. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Variable type is qualitative and its scale is nominal.the criterion of recovery records and descripts based on observations of data collecting man in checklist.relative criterion based on clinical symptoms:1-non-admission along with the return of normal activity-2-non-admission along without the return of normal activity-3-admission without the need for oxygentherapy-4-admission with the need for oxygentherapy-5-admission with the need to receive high speed oxygen from the nose or non invasive ventilation or both-6-admission with the need to receive oxygen therapy with invasive ventilation or oxygen therapy from non pulmonary pathways or both-7- patient's death.;Discharge from hospital. Timepoint: After the start of intervention. Method of measurement: Duration of hospitalization. | — |
Secondary
| Measure | Time frame |
|---|---|
| The blood level of ALT enzyme. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Spectrometer.;The blood level of BUN. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Spectrometer.;The blood level of creatinine. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Spectrometer.;The blood level of AST enzyme. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Spectrometer.;RBC count. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Cell counter.;WBC count. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Cell counter.;The blood level of HG. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Auto analyzer machine.;The blood level of HCT. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Auto analyzer machine.;CRP blood test. Timepoint: Before and 5 days after the start of intervention. Method of measurement: ELISA kits.;ESR test. Timepoint: Before and 5 days after the start of intervention. Method of measurement: Wintrobe method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajad Seyedi
Sabzevar University of Medical Sciences
Outcome results
None listed